Tags

Type your tag names separated by a space and hit enter

Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
Antiviral Res. 2007 Feb; 73(2):112-7.AR

Abstract

The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005.

Authors+Show Affiliations

WHO Collaborating Centre for Reference and Research on Influenza, 45 Poplar Road, Parkville, Melbourne 3052, Australia. Ian.Barr@influenzacenter.orgNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16963130

Citation

Barr, I G., et al. "Increased Adamantane Resistance in Influenza A(H3) Viruses in Australia and Neighbouring Countries in 2005." Antiviral Research, vol. 73, no. 2, 2007, pp. 112-7.
Barr IG, Hurt AC, Iannello P, et al. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Antiviral Res. 2007;73(2):112-7.
Barr, I. G., Hurt, A. C., Iannello, P., Tomasov, C., Deed, N., & Komadina, N. (2007). Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Antiviral Research, 73(2), 112-7.
Barr IG, et al. Increased Adamantane Resistance in Influenza A(H3) Viruses in Australia and Neighbouring Countries in 2005. Antiviral Res. 2007;73(2):112-7. PubMed PMID: 16963130.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. AU - Barr,I G, AU - Hurt,A C, AU - Iannello,P, AU - Tomasov,C, AU - Deed,N, AU - Komadina,N, Y1 - 2006/08/28/ PY - 2006/05/26/received PY - 2006/07/31/revised PY - 2006/08/04/accepted PY - 2006/9/12/pubmed PY - 2007/5/11/medline PY - 2006/9/12/entrez SP - 112 EP - 7 JF - Antiviral research JO - Antiviral Res. VL - 73 IS - 2 N2 - The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005. SN - 0166-3542 UR - https://www.unboundmedicine.com/medline/citation/16963130/Increased_adamantane_resistance_in_influenza_A_H3__viruses_in_Australia_and_neighbouring_countries_in_2005_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0166-3542(06)00256-7 DB - PRIME DP - Unbound Medicine ER -